FDA Finalizes Guidance on Placebos and Blinding for Cancer Trials

The US Food and Drug Administration (FDA) on Wednesday finalized guidance recommending that drugmakers only use placebos in cancer clinical trials in select circumstances due to ethical concerns that would arise when alternative therapies are available.